INSM

Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM)

Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM)  Insider Monkey

INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study

INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study  Stocktwits

(INSM) as a Liquidity Pulse for Institutional Tactics

(INSM) as a Liquidity Pulse for Institutional Tactics  Stock Traders Daily

INSMED (INSM) CEO Lewis exercises options and sells 21,398 shares under 10b5-1 plan

INSMED (INSM) CEO Lewis exercises options and sells 21,398 shares under 10b5-1 plan  Stock Titan

Price to earnings forward of Insmed Incorporated – NASDAQ:INSM

Price to earnings forward of Insmed Incorporated – NASDAQ:INSM  TradingView

William Lewis files Form 144 — Insmed (NASDAQ: INSM) reports recent share dispositions

William Lewis files Form 144 — Insmed (NASDAQ: INSM) reports recent share dispositions  Stock Titan

Insmed (INSM) Stock Valuation After Pullback And Rare Disease Pipeline Debate

Insmed (INSM) Stock Valuation After Pullback And Rare Disease Pipeline Debate  simplywall.st

Cantor Fitzgerald reiterates Insmed stock rating on TPIP data outlook

Cantor Fitzgerald reiterates Insmed stock rating on TPIP data outlook  Investing.com

Is Insmed (INSM) The Best Healthcare Stock to Buy Now?

Is Insmed (INSM) The Best Healthcare Stock to Buy Now?  Yahoo Finance

The Bull Case For Insmed (INSM) Could Change Following New Brinsupri Data And Hiring Push - Learn Why

The Bull Case For Insmed (INSM) Could Change Following New Brinsupri Data And Hiring Push - Learn Why  simplywall.st

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)  PR Newswire

Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%

Insmed's Q1 Earnings Beat, Sales Miss Estimates, Stock Tanks 23%  Yahoo Finance